Article
Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.
Psychiatry research - 30 Jun 2012
Narasimhan Sneha, Aquino Tiffany D, Multani Pushpinder K, Rickels Karl, Lohoff Falk W
Abstract excerpt
Antidepressant drugs are the preferred choice for the treatment of generalized anxiety disorder (GAD). However, the choice of pharmacotherapy is determined on a trial-and-error basis, as the underlying mechanisms of treatment response are unknown. We examined whether the COMT gene, which has been known to play a role in antidepressant treatment response in major depressive disorder (MDD), has a pharmacogenetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
